Ginkgo Bioworks Holdings, Inc.
DNA
$10.17
-$0.59-5.48%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.70% | 15.42% | -90.65% | 74.03% | -30.90% |
| Total Depreciation and Amortization | 2.78% | -1.83% | -8.84% | -0.93% | 34.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.33% | -24.61% | 39.95% | -69.18% | 72.65% |
| Change in Net Operating Assets | -96.39% | -630.75% | 102.22% | -1,767.36% | 1,784.62% |
| Cash from Operations | 21.87% | -21.41% | 59.00% | -22.65% | 5.45% |
| Capital Expenditure | 99.50% | 44.41% | 9.14% | 44.18% | -302.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -85.75% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 66.58% | -33,737.68% | -87.35% | 2,250.26% | -- |
| Cash from Investing | 67.84% | -1,418.41% | -28.28% | 62.00% | -121.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 52.66% | -1.97% | -1.50% | 0.00% | 31.97% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -80.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -562.50% | 93.56% |
| Cash from Financing | 52.66% | -1.97% | 56.34% | -105.75% | 73.25% |
| Foreign Exchange rate Adjustments | 151.35% | 201.37% | -108.57% | -118.75% | 89.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.43% | -348.67% | 51.14% | -2.45% | -8.89% |